Cymabay Therapeu (CBAY) Financials

$32.48

$0.00 (0.00%)

As on 25-Mar-2024 09:30EDT

Market cap

$3,728 Mln

Revenue (TTM)

$31 Mln

P/E Ratio

--

P/B Ratio

12.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	31.07	31.02	--	--	--	--
Cost of Revenue	0.68	0.71	0.69	0.63	0.80	43.75
Gross Profit	30.39	-0.71	-0.69	-0.63	-0.80	-43.75
Operating Expenses	132.07	93.11	87.58	53.31	103.08	72.51
Operating Profit (EBIT)	-101.68	-93.11	-87.58	-52.60	-108.15	-72.51
Other Income	--	2.02	0.17	1.62	--	0.29
Profit before Tax	-105.37	-106.00	-90.00	-50.99	-102.81	-72.55
Provision for Tax	--	12.89	2.58	-2.32	-0.57	0.29
Profit after Tax (Net Income)	-105.37	-118.89	-92.58	-48.67	-102.24	-72.55
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-106.00	-90.00	-50.99	-102.81	-72.55

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	292.26	36.15	132.94	142.71	186.35	170.42
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	105.59	90.26	51.02	1.26	1.74	1.91
Current Liabilities	36.84	15.44	18.37	9.86	17.64	14.42
Total Liabilities	434.69	141.85	202.32	153.83	205.73	186.75

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	30.88	3.78	11.22	2.24	2.80	5.19
Current Assets	403.80	138.07	191.10	151.59	202.92	181.56
Total Assets	434.69	141.85	202.32	153.83	205.73	186.75
Total Debt*	114.49	90.92	51.58	1.74	2.15	--
Net Current Assets	366.96	122.63	172.73	141.73	185.29	167.15

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-72.53	-84.08	-69.43	-44.73	-97.91	-54.94
Cash Flow from Investing Activities	--	-45.99	48.59	47.96	-34.35	-54.11
Cash from Financing Activities	345.77	24.55	118.46	0.09	108.13	134.99
Net Cash Inflow / Outflow	--	-105.52	97.61	3.32	--	25.94

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.99	-1.35	-1.30	-0.71	-1.53	-1.25
Cash EPS ($)	-0.99	-1.34	-1.29	-0.70	-1.52	-1.25
Adjusted Book Value ($)	2.76	0.41	1.87	2.07	2.78	2.94
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.68	-0.96	-0.98	-0.65	-1.46	-0.95
Free Cash Flow per Share ($)	-0.69	-0.96	-0.98	-0.65	-1.47	-0.96

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-39.48	-76.31	-56.29	-29.23	-56.97	-55.49
ROE (%)	-64.17	-140.62	-67.17	-29.58	-57.31	-56.82
ROA (%)	-36.55	-69.09	-51.99	-27.07	-52.10	-49.86
EBIT Margin (%)	-327.23	-300.20	--	--	--	--
Net Margin (%)	-339.10	-359.92	-55,437.72	-3,011.45	--	-24,760.41
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	0.00	--	--	--	--	-1.00
EBIT Growth (%)	-9.20	-6.31	-66.50	51.36	-50.62	-171.20
Net Profit Growth (%)	11.37	-28.42	-90.24	52.40	-40.92	-163.27
EPS Growth (%)	0.26	-0.04	-0.85	0.54	-0.22	-0.59
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	-23.76	-4.64	-2.59	-8.14	-1.28	-6.29
Price / Book Value	8.57	15.26	1.81	2.78	0.70	2.68
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-22.02	-5.57	-1.21	-4.71	0.59	-3.87
Close Price ($)	23.62	6.27	3.38	5.74	1.96	7.87
High Price ($)	25.33	6.42	6.73	9.06	14.00	15.59
Low Price ($)	5.67	1.67	3.14	1.21	1.29	6.31
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.39	2.51	0.39	0.01	0.01	--
Short term debt to equity ratio	0.03	0.02	0.00	0.00	0.00	--
Current Ratio	10.96	8.94	10.41	15.38	11.51	12.60
Quick Ratio	--	--	--	--	--	--
Interest Coverage	-5.37	-6.25	-33.91	-32.55	--	-213.71

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	9.38	--	--	--	--
Asset Turnover	0.11	0.18	--	--	--	--
Receivable days	34.19	34.26	--	--	--	--
Inventory Days	--	--	--	--	--	10.09
Payable days	1,320.48	983.60	785.45	790.03	1,021.79	13.71
Cash Conversion Cycle	--	--	--	--	--	--